MA53225A - Agents inhibiteurs d'ask1 - Google Patents
Agents inhibiteurs d'ask1Info
- Publication number
- MA53225A MA53225A MA053225A MA53225A MA53225A MA 53225 A MA53225 A MA 53225A MA 053225 A MA053225 A MA 053225A MA 53225 A MA53225 A MA 53225A MA 53225 A MA53225 A MA 53225A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibiting agents
- ask1
- ask1 inhibiting
- agents
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862718622P | 2018-08-14 | 2018-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53225A true MA53225A (fr) | 2021-06-23 |
Family
ID=67777431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053225A MA53225A (fr) | 2018-08-14 | 2019-08-13 | Agents inhibiteurs d'ask1 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210317103A1 (fr) |
| EP (1) | EP3837251B1 (fr) |
| JP (1) | JP2021534152A (fr) |
| CN (1) | CN113227070A (fr) |
| AU (1) | AU2019321412A1 (fr) |
| BR (1) | BR112021002690A2 (fr) |
| CA (1) | CA3109504A1 (fr) |
| CO (1) | CO2021003218A2 (fr) |
| ES (1) | ES2963122T3 (fr) |
| MA (1) | MA53225A (fr) |
| MX (1) | MX2021001783A (fr) |
| WO (1) | WO2020036949A1 (fr) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| WO2005040152A1 (fr) * | 2003-10-20 | 2005-05-06 | E.I. Dupont De Nemours And Company | Azolecarboxamides substitues par heterocyclylphenyle et heterocyclylpyridile |
| US7756674B2 (en) * | 2007-08-03 | 2010-07-13 | The Trustees Of Columbia University In The City Of New York | Methods of calculating differences of binding affinities between congeneric pairs of ligands by way of a displaced solvent functional |
| JP5432982B2 (ja) * | 2008-03-31 | 2014-03-05 | 武田薬品工業株式会社 | アポトーシスシグナル調節キナーゼ１阻害剤 |
| US8178555B2 (en) * | 2008-06-24 | 2012-05-15 | Takeda Pharmaceutical Company Limited | Apoptosis signal-regulating kinase 1 inhibitors |
| US8778929B2 (en) * | 2008-09-29 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Substituted heteroaryl inhibitors of B-RAF |
| TWI598347B (zh) * | 2009-07-13 | 2017-09-11 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
| WO2011041293A1 (fr) * | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose |
| WO2011097079A1 (fr) * | 2010-02-03 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Inhibiteurs de kinase 1 régulant le signal d'apoptose |
| EP2588475B1 (fr) * | 2010-07-02 | 2015-05-20 | Gilead Sciences, Inc. | Inhibiteurs des kinases régulant les signaux de l'apoptose |
| CN114907358A (zh) * | 2021-02-09 | 2022-08-16 | 上海翰森生物医药科技有限公司 | 含吡啶多环类衍生物调节剂、其制备方法和应用 |
-
2019
- 2019-08-13 JP JP2021507674A patent/JP2021534152A/ja active Pending
- 2019-08-13 CN CN201980066086.9A patent/CN113227070A/zh active Pending
- 2019-08-13 AU AU2019321412A patent/AU2019321412A1/en not_active Abandoned
- 2019-08-13 EP EP19759814.7A patent/EP3837251B1/fr active Active
- 2019-08-13 WO PCT/US2019/046334 patent/WO2020036949A1/fr unknown
- 2019-08-13 US US17/267,631 patent/US20210317103A1/en active Pending
- 2019-08-13 MA MA053225A patent/MA53225A/fr unknown
- 2019-08-13 BR BR112021002690-8A patent/BR112021002690A2/pt not_active Application Discontinuation
- 2019-08-13 ES ES19759814T patent/ES2963122T3/es active Active
- 2019-08-13 MX MX2021001783A patent/MX2021001783A/es unknown
- 2019-08-13 CA CA3109504A patent/CA3109504A1/fr not_active Abandoned
-
2021
- 2021-03-11 CO CONC2021/0003218A patent/CO2021003218A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3837251B1 (fr) | 2023-06-21 |
| WO2020036949A1 (fr) | 2020-02-20 |
| MX2021001783A (es) | 2021-08-11 |
| ES2963122T3 (es) | 2024-03-25 |
| CN113227070A (zh) | 2021-08-06 |
| BR112021002690A2 (pt) | 2021-05-11 |
| EP3837251A1 (fr) | 2021-06-23 |
| WO2020036949A8 (fr) | 2020-09-10 |
| US20210317103A1 (en) | 2021-10-14 |
| CO2021003218A2 (es) | 2021-03-29 |
| JP2021534152A (ja) | 2021-12-09 |
| AU2019321412A1 (en) | 2021-03-04 |
| CA3109504A1 (fr) | 2020-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44725A (fr) | Formulations d'un inhibiteur de lsd1 | |
| MA50456A (fr) | Formulations d'un inhibiteur de kinase trk macrocyclique | |
| DK3770160T3 (da) | Kontrastmidler baseret på gadolinium-indeholdende pcta | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| MA51616A (fr) | Inhibiteurs d'adn-pk | |
| MA49047A (fr) | Composés inhibiteurs d'ask1 et utilisations associées | |
| UA42295S (uk) | Комп'ютер | |
| MA54521A (fr) | Dérivés d'oxopyridine substitués | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| MA43873A (fr) | Dspositif d'injection | |
| UA42369S (uk) | Комп'ютер | |
| MA53648A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase | |
| MA53009A (fr) | Agents inhibiteurs d'ask1 | |
| MA43764A (fr) | Inhibiteur monovalent de l'interaction hutnfr1 | |
| MA53225A (fr) | Agents inhibiteurs d'ask1 | |
| GB201820756D0 (en) | MJ's-vimana | |
| IT201700035964A1 (it) | “divisorio per boiserie” | |
| MA51199A (fr) | Agents d'imagerie | |
| IT201700090331A1 (it) | "lopemide" | |
| UA41024S (uk) | Графічне зображення «g» | |
| IT201700071679A1 (it) | Remembebe' | |
| MA55203A (fr) | Inhibiteurs d'azétidinyl 0-glyc0pr0téin-2-acétamid0-2-désoxy-3-d-gluc0pyran0sidase | |
| IT201800009293A1 (it) | "divano" | |
| UA40287S (uk) | Емблема «аrabica special» | |
| UA37874S (uk) | Ювелірна прикраса-чокер «клюшка» |